Astromech Buys Form Bio to Combine Evolutionary AI and Genomic Design

Astromech announced on November 17, 2026 that it had acquired Form Bio in an all-stock transaction valued at $230 million, adding the genetic-medicine design company’s intellectual property, selected contracts and assets, and team. The deal pairs Astromech’s evolutionary modeling with Form Bio’s AI tools for designing genetic medicines, optimizing gene-therapy vectors and manufacturing, and assessing genomic quality. The companies’ stated goal is to help researchers move from identifying…

This article has been indexed from Unite.AI